The Global Non-Small Cell Lung Cancer Diagnostics Market was valued at USD 2.39 Billion in 2025 and is expected to reach USD 6.44 Billion by 2033, growing at a CAGR of 13.2% (2026-2033).

The Asia Pacific Cancer Diagnostics market was valued at USD 22 Billion in 2023 and is expected to grow at a CAGR of 8% during the forecast period (2024-2032)....